Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy.

Area of Science:

• Health Economics
• Pharmacoeconomics
• Gene Therapy Research

Background:

• The reference case concept guides economic evaluations in healthcare.
• Gene therapy's unique nature raises questions about applying general economic evaluation methods.
• Existing reference cases may not fully capture gene therapy's complexities.

Purpose of the Study:

• To analyze gene therapy characteristics relevant to economic evaluation.
• To determine if gene therapy necessitates modifications to standard reference case methods.
• To propose a practical tool for evaluating gene therapy cost-effectiveness.

Main Methods:

• Literature review on reference cases and gene therapy.
• Comparative analysis of gene therapy features against general economic evaluation principles.
• Development of a tailored checklist for gene therapy economic evaluations.

Main Results:

• A distinct reference case for gene therapy is not required.
• Gene therapy presents unique challenges for economic evaluation (e.g., long-term effects, novel endpoints).
• A proposed checklist addresses specific methodological considerations for gene therapy.

Conclusions:

• General reference case frameworks can be adapted for gene therapy.
• A tailored checklist enhances the rigor of gene therapy economic evaluations.
• The checklist supports informed decision-making for healthcare interventions involving gene therapy.